Pharmaco - Press Releases

Date	Title	Company
12-Nov-2021	SOT101 Shows Clinical Benefit in Patients with Advanced Solid Tumors	B3C newswire
12-Nov-2021	Ongoing impact of aap's restructuring clearly reflected in Q3 and 9M sales, earnings, and cash flow	aap Implantate AG
12-Nov-2021	Eckert & Ziegler Announces Clinical Trial Notification for Joint Clinical Trial in Japan	Eckert & Ziegler Strahlen- und Medizintechnik AG
12-Nov-2021	Relief Reports that its U.S. Collaboration Partner has Announced it has Received a U.S. Food and Drug Administration Review of Aviptadil Manufacturing Information	RELIEF THERAPEUTICS Holding AG
11-Nov-2021	SeraNovo Enters into a License Agreement with Équilibre BioPharmaceuticals	B3C newswire
11-Nov-2021	Biotest AG: Biotest increases sales by 9% in the first nine months 2021	Biotest AG
11-Nov-2021	RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG closes first nine months of 2021 with increase in revenues	RHÖN-KLINIKUM Aktiengesellschaft
11-Nov-2021	Antibiotic prescribing by GPs in England fell by 17% during the first 12 months of Covid without the usual winter increase	Sciad Newswire
11-Nov-2021	Vita 34 again increases sales and margins in the third quarter	Vita 34 AG
11-Nov-2021	Evotec SE reports results for the first nine months 2021 and provides corporate update	Evotec SE
11-Nov-2021	Relief Provides Corporate Update and Outlines Plans to Advance its Diversified Portfolio of Pipeline Candidates, Including RLF-100(TM) (Aviptadil)	RELIEF THERAPEUTICS Holding AG
11-Nov-2021	STRATEC POSTS SUBSTANTIAL GROWTH AND INCREASED PROFITABILITY IN FIRST NINE MONTHS OF 2021	STRATEC SE
10-Nov-2021	MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results	MorphoSys AG
10-Nov-2021	Secarna Pharmaceuticals and Achilles Therapeutics sign research, option and license agreement to develop optimized T cell therapies	Secarna Pharmaceuticals GmbH & Co. KG
10-Nov-2021	Chemineau develops new nasal spray production line with Flexicon filling system	Sciad Newswire
10-Nov-2021	Epigenomics AG publishes financial results for the first nine months 2021	Epigenomics AG
10-Nov-2021	PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST NINE MONTHS OF 2021	PAION AG
10-Nov-2021	Evotec reaches programme designations in neuroscience collaboration with Bristol Myers Squibb	Evotec SE
10-Nov-2021	SYNLAB delivers strong 9M 2021 results, on track to significantly exceed 2021 financial targets set at IPO	SYNLAB AG
10-Nov-2021	Results of Accelerated Bookbuild Offering of 1,500,000 Existing Shares in PolyPeptide Group AG	PolyPeptide Group